datamatters24/research-document-archive huggingface dataset:
(5) sufficient flexibility to enable the contracts 
to be adjusted in accord with new information re-
lated to projected market size and other factors 
while still maintaining the purchase commitment at 
a fair price. 
(d) TRUST FUND.— 
(1) AUTHORITY TO ESTABLISH.—On the date 
that the Secretary of the Treasury determines that 
a vaccine to combat a neglected disease is available 
for purchase, the Secretary shall establish in the 
Treasury of the United States a fund to be known 
as the Lifesaving Vaccine Purchase Fund consisting 
of amounts appropriated pursuant to paragraph (4). 
(2) INVESTMENT OF FUND.—Amounts in such 
Fund shall be invested in accordance with section 
9702 of title 31, United States Code, and any inter-
est on, and proceeds from any such investment shall 
be credited to and become part of the Fund. 
(3) USE OF FUND.—The Secretary is author-
ized to expend amounts in such Fund for the pur-
chase of a vaccine to combat a neglected disease 
pursuant to an advanced market commitment under-
taken on behalf of the Government of the United 
States.
(4) AUTHORITY TO ACCEPT CONTRIBUTIONS.— 
The President may accept and use in furtherance of 
the purposes of this Act contributions from non-
governmental organizations, international health 
agencies, the United Nations, the Global Fund to 
Fight AIDS, Tuberculosis and Malaria, private non-
profit organizations that are organized to support 
public health research and programs, and any other 
organizations willing to contribute to the Lifesaving 
Vaccine Purchase Fund. 
(5) APPROPRIATIONS.— 
(A) IN GENERAL.—For each fiscal year be-
ginning after the date that the Secretary deter-
mines that a vaccine to combat a neglected dis-
ease is available for purchase, there are author-
ized to be appropriated out of any funds in the 
Treasury not otherwise appropriated such sums 
as may be necessary to carry out the purposes 
of such Fund. 
(B) TRANSFER OF FUNDS.—The Secretary 
shall transfer the amount appropriated under 
paragraph (1) for a fiscal year to such Fund. 
(C) 
AVAILABILITY.—Amounts 
appro-
priated pursuant to this paragraph shall remain
available until expended without fiscal year lim-
itation. 
SEC. 8. CREDIT FOR MEDICAL RESEARCH RELATED TO DE-
VELOPING VACCINES AGAINST NEGLECTED 
DISEASES. 
(a) IN GENERAL.—Subpart D of part IV of sub-
chapter A of chapter 1 of the Internal Revenue Code of 
1986 (relating to business related credits) is amended by 
adding at the end the following new section: 
‘‘SEC. 45J. CREDIT FOR MEDICAL RESEARCH RELATED TO 
DEVELOPING 
VACCINES 
FOR 
NEGLECTED 
DISEASES. 
‘‘(a) GENERAL RULE.—For purposes of section 38, 
the vaccine research credit determined under this section 
for the taxable year is an amount equal to 30 percent of 
the qualified vaccine research expenses for the taxable 
year. 
‘‘(b) QUALIFIED VACCINE RESEARCH EXPENSES.— 
For purposes of this section— 
‘‘(1) 
QUALIFIED
VACCINE
RESEARCH
EX-
PENSES.— 
‘‘(A) IN GENERAL.—Except as otherwise 
provided in this paragraph, the term ‘qualified 
vaccine research expenses’ means the amounts 
which are paid or incurred by the taxpayer dur-
I 
109TH CONGRESS 
1ST SESSION H. R. 3244 
To extend the temporary suspension of duty on quinoline. 
IN THE HOUSE OF REPRESENTATIVES 
JULY 12, 2005 
Mr. BUYER introduced the following bill; which was referred to the Committee 
on Ways and Means 
A BILL 
To extend the temporary suspension of duty on quinoline. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. QUINOLINE. 
(a) IN GENERAL.—Heading 9902.29.61 of the Har-
monized Tariff Schedule of the United States (relating to 
Quinoline) is amended by striking ‘‘12/31/2006’’ and in-
serting ‘‘12/31/2008’’. 
(b) EFFECTIVE DATE.—The amendment made by 
subsection (a) applies to goods entered, or withdrawn from 
warehouse for consumption, on or after the 15th day after 
the date of the enactment of this Act. 
Æ
I 
109TH CONGRESS 
1ST SESSION H. R. 3245 
To reduce temporarily the duty on fluoroxypyr. 
IN THE HOUSE OF REPRESENTATIVES 
JULY 12, 2005 
Mr. BUYER introduced the following bill; which was referred to the Committee 
on Ways and Means 
A BILL 
To reduce temporarily the duty on fluoroxypyr. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. FLUOROXYPYR. 
(a) IN GENERAL.—Heading 9902.29.77 of the Har-
monized Tariff Schedule of the United States (relating to 
Fluoroxypyr) is amended— 
(1) by striking ‘‘1.5%’’ and inserting ‘‘2.5%’’; 
and 
(2) by striking ‘‘12/31/2006’’ and inserting 
‘‘12/31/2008’’. 
(b) EFFECTIVE DATE.—The amendment made by 
subsection (a) applies to goods entered, or withdrawn from
warehouse for consumption, on or after the 15th day after 
the date of the enactment of this Act. 
Æ
are not then currently in effect as permanent law or which 
are subject to discontinuation under certain conditions) 
meet the requirements of paragraph (2) or (3), as the case 
may be, the Secretary of Labor shall thereupon make a cer-
tification to that effect to the Secretary of the Treasury, to-
gether with a certification as to the amount of the incentive 
payment to be transferred to the State account pursuant 
to that finding. The Secretary of the Treasury shall make 
the appropriate transfer within 30 days after receiving such 
certification. 
‘‘(C)(i) No certification of compliance with the require-
ments of paragraph (2) or (3) may be made with respect 
to any State whose State law is not otherwise eligible for 
certification under section 303 or approvable under section 
3304 of the Federal Unemployment Tax Act. 
‘‘(ii) No certification of compliance with the require-
ments of paragraph (3) may be made with respect to any 
State whose State law is not in compliance with the re-
quirements of paragraph (2). 
‘‘(iii) No application under subparagraph (A) may be 
considered if submitted before October 1, 2007, or after the 
latest date necessary (as specified by the Secretary of Labor 
in regulations) to ensure that all incentive payments under 
this subsection are made before October 1, 2012. 
VerDate Aug 31 2005 
01:01 Oct 30, 2007
Jkt 069200
PO 00000
Frm 00093
Fmt 6652
Sfmt 6203
E:\BILLS\H3920.RH
H3920
cnoel on PRODPC60 with BILLS
I 
109TH CONGRESS 
1ST SESSION H. R. 3246 
To extend the temporary suspension of duty on tebufenozide. 
IN THE HOUSE OF REPRESENTATIVES 
JULY 12, 2005 
Mr. BUYER introduced the following bill; which was referred to the Committee 
on Ways and Means 
A BILL 
To extend the temporary suspension of duty on tebufenozide. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. TEBUFENOZIDE. 
(a) IN GENERAL.—Heading 9902.05.17 of the Har-
monized Tariff Schedule of the United States (relating to 
tebufenozide) is amended by striking ‘‘12/31/2006’’ and 
inserting ‘‘12/31/2008’’. 
(b) EFFECTIVE DATE.—The amendment made by 
subsection (a) applies to goods entered, or withdrawn from 
warehouse for consumption, on or after the 15th day after 
the date of the enactment of this Act. 
Æ
‘‘(5)(A) Except as provided in subparagraph (B), any 
amount transferred to the account of a State under this sub-
section may be used by such State only in the payment of 
cash benefits to individuals with respect to their unemploy-
ment (including for dependents’ allowances and for unem-
ployment compensation under paragraph (3)(C)), exclusive 
of expenses of administration. 
‘‘(B) A State may, subject to the same conditions as 
set forth in subsection (c)(2) (excluding subparagraph (B) 
thereof, and deeming the reference to ‘subsections (a) and 
(b)’ in subparagraph (D) thereof to include this subsection), 
use any amount transferred to the account of such State 
under this subsection for the administration of its unem-
ployment compensation law and public employment offices. 
‘‘(6) Out of any money in the Federal unemployment 
account not otherwise appropriated, the Secretary of the 
Treasury shall reserve $7,000,000,000 for incentive pay-
ments under this subsection. Any amount so reserved shall 
not be taken into account for purposes of any determination 
under section 902, 910, or 1203 of the amount in the Fed-
eral unemployment account as of any given time. Any 
amount so reserved for which the Secretary of the Treasury 
has not received a certification under paragraph (4)(B) by 
the deadline described in paragraph (4)(C)(iii) shall, upon 
VerDate Aug 31 2005 
01:01 Oct 30, 2007
Jkt 069200
PO 00000
Frm 00094
Fmt 6652
Sfmt 6203
E:\BILLS\H3920.RH
H3920
cnoel on PRODPC60 with BILLS
I 
109TH CONGRESS 
1ST SESSION H. R. 3247 
To extend the temporary suspension of duty on mixed isomers of 1,3- 
dichloropropene. 
IN THE HOUSE OF REPRESENTATIVES 
JULY 12, 2005 
Mr. BUYER introduced the following bill; which was referred to the Committee 
on Ways and Means 
A BILL 
To extend the temporary suspension of duty on mixed 
isomers of 1,3-dichloropropene. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. MIXED ISOMERS OF 1,3-DICHLOROPROPENE. 
(a) IN GENERAL.—Heading 9902.02.93 of the Har-
monized Tariff Schedule of the United States (relating to 
mixed isomers of 1,3-dichloropropene) is amended by 
striking ‘‘12/31/2006’’ and inserting ‘‘12/31/2008’’. 
(b) EFFECTIVE DATE.—The amendment made by 
subsection (a) applies to goods entered, or withdrawn from
warehouse for consumption, on or after the 15th day after 
the date of the enactment of this Act. 
Æ
(d) EFFECTIVE DATE.—The amendments made by 
this section shall apply to sales of vaccines after December 
31, 2005, in taxable years ending after such date. 
SEC. 10. SBIR AND STTR PROGRAM FUNDING FOR VACCINE 
DEVELOPMENT. 
(a) PILOT PROGRAM.—Section 9 of the Small Busi-
ness Act (15 U.S.C. 638) is amended by adding at the 
end the following: 
‘‘(x) REQUIRED EXPENDITURES FOR THE DEVELOP-
MENT OF VACCINES FOR NEGLECTED DISEASES.— 
‘‘(1) SBIR EXPENDITURES.—Each agency re-
quired to make expenditures under subsection (f)(1) 
or under subsection (n)(1), that is determined by the 
Administrator to have a mission related to global 
health or disease prevention shall expend with small 
business concerns, in addition to any amounts re-
quired to be expended under subsections (f) and (n), 
not less than $10,000,000 for fiscal year 2006 and 
each fiscal year thereafter, specifically in connection 
with SBIR and STTR programs which meet the re-
quirements of this section, policy directives, and reg-
ulations to carry out this section, to carry out the 
pilot program established under this subsection. 
‘‘(2) PILOT PROGRAM.—During the 4-year pe-
riod beginning on the date of enactment of the Vac-
cines for the New Millennium Act of 2005, the Ad-
ministrator shall establish and carry out a program 
to encourage the development of vaccines and 
microbicides to combat a neglected disease, including 
outreach activities to raise awareness of such pro-
gram. 
‘‘(3) ADMINISTRATIVE COSTS.—The limitations 
in subsection (f)(2) and (n)(2) shall not apply to 
agency expenditures under the pilot program estab-
lished under this subsection. 
‘‘(4) REPORT.—Six months before the date of 
expiration of the pilot program established under 
this subsection, the Administrator shall submit to 
the Committee on Small Business and Entrepre-
neurship of the Senate and the Committee on Small 
Business of the House of Representatives a report 
containing an assessment of whether the pilot pro-
gram is meeting the objective of providing incentives 
to small business concerns to research the develop-
ment of vaccines and microbicides to combat a ne-
glected disease, and an accounting of the expendi-
tures for the pilot program. 
‘‘(5) DEFINITIONS.—As used in this subsection 
and subsection (j), the terms ‘neglected disease’ and 
‘developing country’ have the same meanings as in
(A) the role and overall cost of credit card 
interchange rates on gasoline and diesel fuel re-
tail prices; and 
(B) the varying cost of credit card inter-
change rates that are applied to different chan-
nels of trade. 
(b) SUBJECT COMPANIES.—The companies subject to 
the investigation required by this section shall be— 
(1) any company with total United States whole-
sale sales of gasoline and petroleum distillates for cal-
endar year 2004 in excess of $500,000,000; and 
(2) any retail distributor of gasoline and petro-
leum distillates against which multiple formal com-
plaints (that identify the location of the particular re-
tail distributor and provide contact information for 
the complainant) of price-gouging were filed in Au-
gust or September 2005, with a Federal or State con-
sumer protection agency. 
(c) EVIDENCE OF PRICE-GOUGING.—In conducting its 
investigation, the Commission shall treat as evidence of 
price-gouging any finding that the average price of gasoline 
available for sale to the public in September, 2005, or there-
after in a market area located in an area designated as 
a State or National disaster area because of Hurricane 
Katrina, or in any other area where price-gouging com-
plaints have been filed because of Hurricane Katrina with 
a Federal or State consumer protection agency, exceeded the 
average price of such gasoline in that area for the month 
of August, 2005, unless the Commission finds substantial 
evidence that the increase is substantially attributable to 
additional costs in connection with the production, trans-
portation, delivery, and sale of gasoline in that area or to 
national or international market trends. 
(d) REPORTS.— 
(1) NOTIFICATION TO STATE AGENCIES.—In any 
areas of markets in which the Commission determines 
price increases are due to factors other than the addi-
tional costs, it shall also notify the appropriate State 
agency of its findings. 
(2) PROGRESS
AND
FINAL
REPORTS
TO
CON-
GRESS.—The Commission shall provide information 
on the progress of the investigation to the Appropria-
tions Committees of the House of Representatives and 
the Senate, the Committee on Energy and Commerce 
of the House of Representatives, and the Committee 
on Commerce, Science, and Transportation of the 
Senate, every 30 days after the date of enactment of 
this Act. The Commission shall provide those Com-
mittees a written interim report 90 days after such 
date, and shall transmit a final report to those Com-
section 2 of the Vaccines for the New Millennium 
Act of 2005.’’. 
(b) POLICY OBJECTIVES.—Section 9(j) of the Small 
Business Act (15 U.S.C. 638(j)) is amended by adding 
at the end the following: 
‘‘(4) ADDITIONAL MODIFICATIONS FOR THE DE-
VELOPMENT OF VACCINES FOR A NEGLECTED DIS-
EASE.—Not later than 90 days after the date of en-
actment of the Vaccines for the New Millennium Act 
of 2005, the Administrator shall modify the policy 
directives issued pursuant to this subsection to en-
sure that agencies participating in the SBIR and 
STTR programs develop an action plan for imple-
menting the pilot program for the development of 
vaccines and microbicides to combat a neglected dis-
ease under subsection (x), including outreach to 
raise awareness of the pilot program.’’. 
Æ
124 
amended by striking ‘‘December 31, 2008’’ and inserting 
‘‘December 31, 2011’’. 
(b) EFFECTIVE DATE.—The amendments made by this 
section shall apply to taxable years beginning after Decem-
ber 31, 2008. 
VerDate Aug 31 2005 
01:01 Oct 30, 2007
Jkt 069200
PO 00000
Frm 00124
Fmt 6652
Sfmt 6203
E:\BILLS\H3920.RH
H3920
cnoel on PRODPC60 with BILLS
may teach multiple subjects, special 
educators, teachers of students who 
are limited English proficient who 
may teach multiple subjects, and 
teachers who are qualified to teach 
Advanced Placement or International 
Baccalaureate courses); and 
‘‘(II) such teachers to understand 
empirically based practice and sci-
entifically based research on teaching 
and learning and its applicability, and 
to use technology effectively, including 
the use of instructional techniques to 
improve student achievement; and 
‘‘(ii) promoting strong teaching skills. 
‘‘(B) REQUIRED REFORMS.—The reforms 
described in subparagraph (A) shall include— 
‘‘(i) implementing teacher preparation 
program curriculum changes that improve, 
evaluate, and assess how well all prospec-
tive and new teachers develop teaching 
skills; 
‘‘(ii) using empirically based practice 
and scientifically based research about the 
VerDate Aug 31 2005 
01:45 Oct 05, 2007
Jkt 069200
PO 00000
Frm 00074
Fmt 6652
Sfmt 6201
E:\BILLS\H3746.IH
H3746
cnoel on PRODPC60 with BILLS
V 
109TH CONGRESS 
1ST SESSION H. R. 3783 
For the relief of Abraham Jaars, Delicia Jaars, and Grant Jaars. 
IN THE HOUSE OF REPRESENTATIVES 
SEPTEMBER 14, 2005 
Mr. TIBERI introduced the following bill; which was referred to the Committee 
on the Judiciary 
A BILL 
For the relief of Abraham Jaars, Delicia Jaars, and Grant 
Jaars. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. WAIVER OF GROUNDS FOR REMOVAL OF, OR 
DENIAL OF ADMISSION TO, ABRAHAM JAARS, 
DELICIA JAARS, AND GRANT JAARS. 
(a) IN GENERAL.—Notwithstanding sections 212(a) 
and 237(a) of the Immigration and Nationality Act, Abra-
ham Jaars, Delicia Jaars, and Grant Jaars may not be 
removed from the United States, or denied admission to 
the United States, by reason of any act that is a ground 
for removal or denial of admission and is reflected in the
records of the Immigration and Naturalization Service of 
the Department of Justice, or the Visa Office of the De-
partment of State, on the date of the enactment of this 
Act. 
(b) RESCISSION OF OUTSTANDING ORDER OF RE-
MOVAL.—The Attorney General shall rescind any out-
standing order of removal or deportation, or any finding 
of deportability, that has been entered against Abraham 
Jaars, Delicia Jaars, or Grant Jaars by reason of any act 
described in subsection (a). 
Æ
disciplines of teaching and learning so that 
all prospective teachers— 
‘‘(I) can understand and imple-
ment research-based teaching prac-
tices in classroom-based instruction; 
‘‘(II) have knowledge of student 
learning methods; 
‘‘(III) possess skills to analyze 
student academic achievement data 
and other measures of student learn-
ing and use such data and measures 
to improve instruction in the class-
room; 
‘‘(IV) possess teaching skills and 
an understanding of effective instruc-
tional strategies across all applicable 
content areas that enable the teachers 
to— 
‘‘(aa) 
meet 
the 
specific 
learning needs of all students, in-
cluding students with disabilities, 
students who are limited English 
proficient, students who are gift-
ed and talented, and students 
with low literacy levels; and 
VerDate Aug 31 2005 
01:45 Oct 05, 2007
Jkt 069200
PO 00000
Frm 00075
Fmt 6652
Sfmt 6201
E:\BILLS\H3746.IH
H3746
cnoel on PRODPC60 with BILLS
109TH CONGRESS 
1ST SESSION H. R. 3784
AN ACT 
To temporarily extend the programs under the Higher 
Education Act of 1965, and for other purposes.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Higher Education Ex-
tension Act of 2005’’. 
SEC. 2. EXTENSION OF PROGRAMS. 
(a) EXTENSION OF DURATION.—The authorization 
of appropriations for, and the duration of, each program 
authorized under the Higher Education Act of 1965 (20 
U.S.C. 1001 et seq.) shall be extended through December 
31, 2005. 
(b) PERFORMANCE OF REQUIRED AND AUTHORIZED 
FUNCTIONS.—If the Secretary of Education, a State, an 
institution of higher education, a guaranty agency, a lend-
er, or another person or entity—
(1) is required, in or for fiscal year 2004, to 
carry out certain acts or make certain determina-
tions or payments under a program under the High-
er Education Act of 1965, such acts, determinations, 
or payments shall be required to be carried out, 
made, or continued during the period of the exten-
sion under this section; or 
(2) is permitted or authorized, in or for fiscal 
year 2004, to carry out certain acts or make certain 
determinations or payments under a program under 
the Higher Education Act of 1965, such acts, deter-
minations, or payments are permitted or authorized
VerDate Aug 31 2005 
01:01 Oct 30, 2007
Jkt 069200
PO 00000
Frm 00125
Fmt 6652
Sfmt 6203
E:\BILLS\H3920.RH
H3920
cnoel on PRODPC60 with BILLS
I 
109TH CONGRESS 
1ST SESSION H. R. 3249 
To amend title II of the Social Security Act to eliminate reconsideration 
as an intervening step between initial benefit entitlement decisions and 
subsequent hearings on the record on such decisions. 
IN THE HOUSE OF REPRESENTATIVES 
JULY 12, 2005 
Mr. GOODE introduced the following bill; which was referred to the Committee 
on Ways and Means 
A BILL 
To amend title II of the Social Security Act to eliminate 
reconsideration as an intervening step between initial 
benefit entitlement decisions and subsequent hearings on 
the record on such decisions. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as ‘‘Social Security Disability 
Determination Simplification Act of 2005’’.
SEC. 2. ELIMINATION OF RECONSIDERATION IN THE RE-
VIEW PROCESS GOVERNING DECISIONS ON 
BENEFIT ENTITLEMENT. 
(a) IN GENERAL.—Section 205(b)(1) of the Social 
Security Act (42 U.S.C. 405(b)(1)) is amended by adding 
at the end the following new sentence: ‘‘Opportunity for 
a hearing under this title in accordance with this sub-
section with respect to any initial decision or determina-
tion under this title shall be available without any require-
ment for intervening reconsideration.’’. 
(b) CONFORMING AMENDMENTS.—Section 205(b) of 
such Act is amended— 
(1) by striking paragraph (2); and 
(2) by redesignating paragraph (3) as para-
graph (2). 
(c) EFFECTIVE DATE.—The amendments made by 
this section shall apply with respect to initial decisions and 
determinations (subject to opportunity for a hearing to the 
extent provided under section 205(b) of the Social Secu-
rity Act) issued after 1 year after the date of the enact-
ment of this Act. 
Æ